The Role of AI/ML in Medical Product Development and Regulatory Science

Description

Join host William Barrier for a thought-provoking discussion with Jonathan Helfgott on the evolving role of artificial intelligence (AI) and machine learning (ML) in the development of medical products and how these technologies intersect with regulatory science.

Helfgott will discuss how AI/ML is shaping drug and device development, clinical trials, and the regulatory review process. The session will provide insights into both the current applications and future potential of AI/ML within the regulatory landscape, with a focus on challenges and opportunities for industry stakeholders.

Please attend the event by using the Zoom link.

Helfgott is a senior lecturer and program coordinator at Johns Hopkins in the MS in Regulatory Science program. Outside of Johns Hopkins, Helfgott is the executive director of global regulatory/clinical affairs and market access at Stage 2 Innovations. Prior to joining Stage 2 Innovations, Helfgott was the associate director for risk science within the Office of Scientific Investigations at the Food and Drug Administration's Center for Drug Evaluation & Research.

Learn more about the Johns Hopkins MS in Regulatory Science, a program within the Center for Biotechnology Education.